title: National guidelines for the management of absolute cardiovascular disease risk.
authors.affiliation: Austin Health, Melbourne, VIC, Australia. Christopher.ocallaghan@austin.org.au.
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: O'Callaghan
authors.affiliation: Austin Health, Melbourne, VIC, Australia.
authors.forename: Pei
authors.initials: P
authors.lastname: Rong
authors.affiliation: Austin Health, Melbourne, VIC, Australia.
authors.forename: Min Y
authors.initials: MY
authors.lastname: Goh
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D001315:Australia; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000517:prevention & control; D019468:Disease Management; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D012307:Risk Factors
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors